Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ
Market Cap
$598.23M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
299 of 809
Rank in Industry
175 of 445
Largest Insider Buys in Sector
PHAT Stock Price History Chart
PHAT Stock Performance
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Insider Activity of Phathom Pharmaceuticals, Inc.
Over the last 12 months, insiders at Phathom Pharmaceuticals, Inc. have bought $58,580 and sold $30.37M worth of Phathom Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Phathom Pharmaceuticals, Inc. have bought $12.44M and sold $23.25M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Parikh Asit (director) — $58,580.
The last purchase of 2,500 shares for transaction amount of $19,500 was made by Parikh Asit (director) on 2023‑11‑08.
List of Insider Buy and Sell Transactions, Phathom Pharmaceuticals, Inc.
| 2024-04-08 | Sale | Henderson Molly | CFO and CBO | 3,435 0.0059% | $11.10 | $38,129 | -7.20% | |
| 2024-03-22 | Sale | Curran Terrie | President and Chief Executive | 16,851 0.0238% | $9.11 | $153,513 | -6.13% | |
| 2024-01-24 | Sale | TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 3.7M 7.8033% | $8.10 | $30M | +49.52% | |
| 2024-01-19 | Sale | Henderson Molly | CFO and CBO | 6,307 0.0114% | $7.75 | $48,900 | +34.09% | |
| 2023-11-20 | Sale | Henderson Molly | CFO and CBO | 2,127 0.0037% | $7.24 | $15,403 | +23.09% | |
| 2023-11-08 | Parikh Asit | director | 2,500 0.0044% | $7.80 | $19,500 | +16.96% | ||
| 2023-11-07 | Parikh Asit | director | 4,000 0.0067% | $7.76 | $31,040 | +11.76% | ||
| 2023-11-06 | Parikh Asit | director | 1,000 0.0018% | $8.04 | $8,040 | +14.79% | ||
| 2023-11-01 | Sale | Henderson Molly | CFO and CBO | 12,492 0.0202% | $8.88 | $110,871 | -5.31% | |
| 2023-06-02 | Sale | Henderson Molly | CFO and CBO | 1,960 0.0045% | $11.41 | $22,368 | -13.46% | |
| 2023-05-22 | Sale | Henderson Molly | CFO and CBO | 2,110 0.0048% | $12.87 | $27,165 | -24.78% | |
| 2023-04-11 | Nabulsi Azmi | Chief Operating Officer | 10,000 0.0243% | $8.26 | $82,600 | +26.97% | ||
| 2023-04-10 | Parikh Asit | director | 1,000 0.0023% | $7.55 | $7,550 | +29.28% | ||
| 2023-04-06 | Sale | Henderson Molly | CFO and CBO | 3,439 0.0079% | $7.27 | $25,002 | +34.68% | |
| 2023-04-06 | Curran Terrie | President and Chief Executive | 12,919 0.0318% | $7.82 | $101,025 | +34.68% | ||
| 2023-03-01 | Sale | Curran Terrie | President and Chief Executive | 1,436 0.0033% | $8.54 | $12,265 | +13.21% | |
| 2023-03-01 | Sale | Henderson Molly | CFO and CBO | 2,032 0.0047% | $8.53 | $17,335 | +13.21% | |
| 2023-02-13 | Parikh Asit | director | 5,000 0.0118% | $7.73 | $38,660 | +25.35% | ||
| 2023-01-20 | Sale | Curran Terrie | President and Chief Executive | 5,821 0.0134% | $8.20 | $47,729 | +20.09% | |
| 2023-01-12 | Parikh Asit | director | 5,000 0.0115% | $7.00 | $35,000 | +39.91% |
Insider Historical Profitability
38.59%
| TAKEDA PHARMACEUTICAL CO LTD | 10 percent owner | 3755583 6.5597% | $10.22 | 0 | 36 | |
| Curran Terrie | President and Chief Executive | 410784 0.3289% | $10.22 | 2 | 5 | +28.29% |
| Henderson Molly | CFO and CBO | 95263 0.1724% | $10.22 | 1 | 9 | |
| Parikh Asit | director | 55000 0.0961% | $10.22 | 7 | 0 | +33.82% |
| Frazier Life Sciences IX, L.P. | 10 percent owner | 7284269 12.7231% | $10.22 | 1 | 0 | +47.21% |
| RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | 3115008 5.4408% | $10.22 | 3 | 1 | +53.57% |
| Edwards Jonathan S. | director | 2019877 3.528% | $10.22 | 1 | 0 | +47.21% |
| Socks David A | director | 1211346 2.1158% | $10.22 | 0 | 24 | |
| Nabulsi Azmi | Chief Operating Officer | 99567 0.1739% | $10.22 | 2 | 13 | +23.01% |
| COLA MICHAEL F | director | 9798 0.0171% | $10.22 | 1 | 0 | +47.21% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Frazier Life Sciences Management L P | $107.36M | 17.27 | 10.11M | 0% | +$0 | 5.51 | |
| Medicxi Growth I Lp | $79.27M | 12.75 | 7.46M | +98.48% | +$39.33M | 20.79 | |
| The Carlyle Group | $37.1M | 5.97 | 3.5M | 0% | +$0 | 1.61 | |
| Invesco | $33.56M | 5.4 | 3.16M | -0.25% | -$83,515.68 | 0.01 | |
| BlackRock | $29.16M | 4.69 | 2.75M | +2.48% | +$706,113.17 | <0.01 | |
| Ensign Peak Advisors Inc | $24.21M | 3.9 | 2.28M | 0% | +$0 | 0.04 | |
| The Vanguard Group | $21.02M | 3.38 | 1.98M | +1.16% | +$240,904.08 | <0.0001 | |
| Nea Management Company Llc | $20.82M | 3.35 | 1.96M | 0% | +$0 | 0.24 | |
| Avidity Partners Management Lp | $18.43M | 2.96 | 1.74M | +0.78% | +$142,520.40 | 0.67 | |
| 683 Capital Management Llc | $17.52M | 2.82 | 1.65M | +28.91% | +$3.93M | 1.97 | |
| JENNISON ASSOCIATES LLC | $17.5M | 2.82 | 1.65M | New | +$17.5M | 0.01 | |
| Gilder Gagnon Howe & Co. LLC | $10.81M | 1.74 | 1.02M | -30.07% | -$4.65M | 0.14 | |
| Geode Capital Management | $7.98M | 1.28 | 751,379 | +2.19% | +$171,074.27 | <0.01 | |
| State Street | $7.62M | 1.23 | 717,201 | +4.27% | +$311,845.70 | <0.0001 | |
| Kennedy Capital Management Inc | $6.08M | 0.98 | 572,336 | +0.06% | +$3,823.20 | 0.13 | |
| GW&K Investment Management | $6.03M | 0.97 | 568,026 | +1.16% | +$69,407.30 | 0.05 | |
| Woodline Partners LP | $6.02M | 0.97 | 566,439 | -48.32% | -$5.63M | 0.06 | |
| Simplify Asset Management Inc | $5.54M | 0.89 | 521,935 | +119.36% | +$3.02M | 0.53 | |
| Saturn V Capital Management Llc | $5.32M | 0.86 | 500,987 | +212.97% | +$3.62M | 2.13 | |
| GHOST TREE CAPITAL LLC | $5.15M | 0.83 | 485,000 | +25.89% | +$1.06M | 1.67 | |
| Two Sigma | $4.96M | 0.8 | 467,448 | +75.17% | +$2.13M | 0.01 | |
| Octagon Capital Advisors LP | $4.83M | 0.78 | 455,000 | +810% | +$4.3M | 0.63 | |
| StepStone Group | $4.48M | 0.72 | 422,085 | 0% | +$0 | 0.96 | |
| HERITAGE ASSET MANAGEMENT INC | $3.23M | 0.52 | 304,839 | New | +$3.23M | 0.02 | |
| Northern Trust | $3.01M | 0.48 | 283,200 | -2.28% | -$70,293.78 | <0.01 | |
| Charles Schwab | $2.81M | 0.45 | 264,494 | +0.75% | +$20,921.40 | <0.01 | |
| Nuveen | $2.78M | 0.45 | 262,048 | -13.97% | -$451,997.86 | <0.01 | |
| Morgan Stanley | $2.52M | 0.41 | 237,160 | +90.41% | +$1.2M | <0.0001 | |
| Millennium Management LLC | $2.39M | 0.38 | 225,024 | +32.33% | +$583,887.63 | <0.01 | |
| Wellington Management Company | $2.37M | 0.38 | 223,390 | +44.69% | +$732,769.13 | <0.0001 | |
| Goldman Sachs | $2.2M | 0.35 | 207,372 | -1.35% | -$30,150.19 | <0.0001 | |
| Newtyn Management | $1.75M | 0.28 | 165,000 | -74.49% | -$5.12M | 0.38 | |
| Schonfeld Group | $1.54M | 0.25 | 144,700 | +137.21% | +$888,894.00 | 0.01 | |
| JPMorgan Chase | $1.47M | 0.24 | 138,452 | -5.19% | -$80,552.69 | <0.0001 | |
| Citadel Advisors LLC | $1.33M | 0.22 | 125,645 | +989.44% | +$1.21M | <0.01 | |
| Moore Capital Management | $1.27M | 0.21 | 120,000 | +20% | +$212,400.00 | 0.03 | |
| Bank of America | $1.12M | 0.18 | 105,855 | +29.42% | +$255,538.64 | <0.0001 | |
| BNY Mellon | $1.01M | 0.16 | 95,221 | -10.44% | -$117,860.64 | <0.0001 | |
| D. E. Shaw & Co. | $681,146.00 | 0.11 | 64,138 | -50.43% | -$692,966.07 | <0.01 | |
| Penn Mutual Asset Management, LLC | $666,957.00 | 0.11 | 62,802 | 0% | +$0 | 2.17 | |
| Susquehanna International Group | $631,221.00 | 0.1 | 59,437 | +13.62% | +$75,656.89 | <0.01 | |
| State of Wisconsin Investment Board | $628,555.00 | 0.1 | 59,186 | +25.09% | +$126,080.58 | <0.01 | |
| Swiss National Bank | $594,720.00 | 0.1 | 56,000 | 0% | +$0 | <0.0001 | |
| Two Sigma Advisers LP | $547,992.00 | 0.09 | 51,600 | +127.31% | +$306,918.00 | <0.01 | |
| UBS | $530,183.00 | 0.09 | 49,923 | +26.61% | +$111,414.57 | <0.0001 | |
| RhumbLine Advisers | $500,225.00 | 0.08 | 47,103 | -2.88% | -$14,857.12 | <0.0001 | |
| Credit Suisse | $421,434.00 | 0.07 | 39,683 | +4.33% | +$17,491.16 | <0.0001 | |
| Inspirion Wealth Advisors LLC | $373,123.00 | 0.06 | 35,134 | 0% | +$0 | 0.07 | |
| Legal & General | $362,164.00 | 0.06 | 34,102 | -0.44% | -$1,603.62 | <0.0001 | |
| AllianceBernstein | $342,920.00 | 0.06 | 32,290 | -14.35% | -$57,454.23 | <0.0001 |